A newly discovered genetic condition caused by faulty protein synthesis which causes delayed development and learning difficulties could be treated by a compound originally isolated from human sperm, ...

and Harvard University took a fresh approach by building a remarkably diverse collection of molecular compounds that can be mined for those that target disease-related genetic variants in new ways.

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness.

The Direct-to-Consumer Genetic Testing market is anticipated to sustain a robust Compound Annual Growth Rate (CAGR) of 9.45% ...